Powder: -20°C for 3 years | In solvent: -80°C for 1 year
SHP2-IN-13 is an orally active, highly selective allosteric inhibitor targeting the SHP2 “tunnel site,” exhibiting an IC50 of 83.0 nM. It holds potential for research into cancers with RTK oncogenic drivers and diseases associated with SHP2.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 1,520.00 | |
50 mg | 6-8 weeks | $ 1,980.00 | |
100 mg | 6-8 weeks | $ 2,500.00 |
Description | SHP2-IN-13 is an orally active, highly selective allosteric inhibitor targeting the SHP2 “tunnel site,” exhibiting an IC50 of 83.0 nM. It holds potential for research into cancers with RTK oncogenic drivers and diseases associated with SHP2. |
In vitro | SHP2-IN-13 (compound 129) effectively inhibits the pERK signaling pathway in a dose-dependent manner, with IC50 values of 0.59 μM in NSCLC cells and 0.63 ± 0.32 μM in NCI-H1975-OR cells [1]. At concentrations ranging from 0 to 30 μM over 24 hours, it suppresses both the pERK levels and proliferation driven by receptor tyrosine kinases (RTK) in NCI-H1975 cells, as well as inhibits the phosphorylated ERK (pERK) levels in RTK-resistant NSCLC cells [1]. |
In vivo | In pharmacokinetic studies, SHP2-IN-13 (compound 129) (IV/PO; 5mg/kg) demonstrated high clearance, substantial volume of distribution (13.9 L/kg), and a moderate half-life (T 1/2 = 5.31 h), with oral bioavailability (F= 55.07±7.93%) exceeding that of SHP099 (F= 46%), making it suitable for further in vivo antitumor pharmacodynamic evaluation [1]. SHP2-IN-13 (oral gavage; 20 mg/kg; daily) exhibited potent anti-leukemic efficacy, which significantly reduced leukemic burden, and nearly eradicated CD45+ leukemic cells from human blood and spleen samples [1]. |
Molecular Weight | 327.38 |
Formula | C16H21N7O |
CAS No. | 2951854-02-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
SHP2-IN-13 2951854-02-5 inhibitor inhibit